Penserra Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8K | Buy |
114
+6
| +6% | +$484 | ﹤0.01% | 918 |
|
|
2026
Q1 | $9K | Hold |
108
| – | – | ﹤0.01% | 881 |
|
|
2025
Q4 | $10K | Hold |
108
| – | – | ﹤0.01% | 852 |
|
|
2025
Q3 | $10K | Hold |
108
| – | – | ﹤0.01% | 844 |
|
|
2025
Q2 | $9K | Sell |
108
-8,778
| -99% | -$744K | ﹤0.01% | 826 |
|
|
2025
Q1 | $797K | Buy |
8,886
+5,529
| +165% | +$495K | 0.01% | 505 |
|
|
2024
Q4 | $267K | Buy |
3,357
+3,249
| +3,008% | +$281K | ﹤0.01% | 691 |
|
|
2024
Q3 | $9K | Hold |
108
| – | – | ﹤0.01% | 896 |
|
|
2024
Q2 | $9K | Hold |
108
| – | – | ﹤0.01% | 938 |
|
|
2024
Q1 | $9K | Sell |
108
-6,048
| -98% | -$516K | ﹤0.01% | 935 |
|
|
2023
Q4 | $506K | Sell |
6,156
-1,298
| -17% | -$98.9K | 0.01% | 534 |
|
|
2023
Q3 | $583K | Sell |
7,454
-1,163
| -13% | -$97.4K | 0.01% | 469 |
|
|
2023
Q2 | $758K | Buy |
8,617
+8,545
| +11,868% | +$736K | 0.02% | 423 |
|
|
2023
Q1 | $5K | Sell |
72
-37,669
| -100% | -$3.07M | ﹤0.01% | 951 |
|
|
2022
Q4 | $2.93M | Buy |
+37,741
| New | +$3.06M | 0.06% | 294 |
|
|
2021
Q4 | – | Sell |
-162,709
| Closed | -$20.4M | – | 1471 |
|
|
2021
Q3 | $20.4M | Buy |
162,709
+37,048
| +29% | +$4.8M | 0.42% | 59 |
|
|
2021
Q2 | $15.6M | Buy |
+125,661
| New | +$15.8M | 0.28% | 117 |
|
|
2020
Q4 | – | Sell |
-780
| Closed | -$81K | – | 1090 |
|
|
2020
Q3 | $81K | Sell |
780
-104
| -12% | -$10.4K | ﹤0.01% | 531 |
|
|
2020
Q2 | $81K | Sell |
884
-166
| -16% | -$15.9K | ﹤0.01% | 609 |
|
|
2020
Q1 | $103K | Buy |
1,050
+182
| +21% | +$19.4K | 0.01% | 564 |
|
|
2019
Q4 | $102K | Sell |
868
-11,871
| -93% | -$1.3M | 0.01% | 592 |
|
|
2019
Q3 | $1.38M | Buy |
12,739
+143
| +1% | +$14.9K | 0.12% | 189 |
|
|
2019
Q2 | $1.23M | Buy |
12,596
+1,233
| +11% | +$113K | 0.1% | 197 |
|
|
2019
Q1 | $1.01M | Sell |
11,363
-2,142
| -16% | -$192K | 0.08% | 222 |
|
|
2018
Q4 | $1.23M | Buy |
+13,505
| New | +$1.26M | 0.12% | 190 |
|
|
2018
Q1 | – | Sell |
-4,404
| Closed | -$355K | – | 514 |
|
|
2017
Q4 | $355K | Buy |
4,404
+489
| +12% | +$39.2K | 0.05% | 160 |
|
|
2017
Q3 | $304K | Buy |
+3,915
| New | +$325K | 0.07% | 133 |
|
|
2017
Q1 | – | Sell |
-291
| Closed | -$20K | – | 734 |
|
|
2016
Q4 | $20K | Buy |
291
+61
| +27% | +$4.79K | ﹤0.01% | 622 |
|
|
2016
Q3 | $19K | Buy |
230
+92
| +67% | +$8.02K | ﹤0.01% | 532 |
|
|
2016
Q2 | $12K | Buy |
138
+56
| +68% | +$4.53K | ﹤0.01% | 546 |
|
|
2016
Q1 | $6K | Buy |
+82
| New | +$6.18K | ﹤0.01% | 700 |
|
Other funds holding MDT
Penserra Capital Management's MDT Position: Q2 2026 in Review
Penserra Capital Management increased its Medtronic (MDT) stake by 5.6% in Q2 2026, buying an estimated $484 and bringing the position to 114 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #918.
Penserra Capital Management first reported a position in MDT in Q1 2016 and has held it in 31 quarters since. The position peaked at $20.4M in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Penserra Capital Management held 114 shares of Medtronic worth $8K as of Q2 2026.
- Penserra Capital Management bought 6 Medtronic shares in Q2 2026, an estimated $484.
- Medtronic made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #918 holding.
- Penserra Capital Management first reported a position in Medtronic in Q1 2016 and has held it in 31 quarters since.
- Penserra Capital Management's Medtronic position peaked at $20.4M in Q3 2021.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.